254 related articles for article (PubMed ID: 10770726)
1. Introduction to antifungal drugs.
Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):653-7. PubMed ID: 10770726
[No Abstract] [Full Text] [Related]
2. Antifungal drugs.
Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
[No Abstract] [Full Text] [Related]
3. Recent approaches to antifungal therapy for invasive mycoses.
Mathew BP; Nath M
ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
[TBL] [Abstract][Full Text] [Related]
4. The evolution of azole compounds in antifungal chemotherapy.
Borgers M
J Chemother; 1989 Jul; 1(4 Suppl):238-40. PubMed ID: 16312384
[No Abstract] [Full Text] [Related]
5. [Antifungals for systemic use].
Ruiz-Camps I; Cuenca-Estrella M
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
[TBL] [Abstract][Full Text] [Related]
6. Antifungal drugs.
Treat Guidel Med Lett; 2008 Jan; 6(65):1-8. PubMed ID: 18157085
[No Abstract] [Full Text] [Related]
7. [In vitro resistance of Candida species to antifungal agents].
Banach-Piatkowska W; Kotłowski A; Humanowska J; Mayer L; Kowalczyk D
Wiad Parazytol; 2001; 47(4):811-6. PubMed ID: 16886432
[TBL] [Abstract][Full Text] [Related]
8. Second-generation azole antifungal agents.
Kale P; Johnson LB
Drugs Today (Barc); 2005 Feb; 41(2):91-105. PubMed ID: 15821782
[TBL] [Abstract][Full Text] [Related]
9. Antifungals in Clinical Use and the Pipeline.
Johnson MD
Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281
[TBL] [Abstract][Full Text] [Related]
10. Antifungal resistance among Candida species.
Klepser ME
Pharmacotherapy; 2001 Aug; 21(8 Pt 2):124S-132S. PubMed ID: 11501986
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic implications for use of antifungal agents.
Lewis RE
Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.
Brüggemann RJ; Alffenaar JW; Blijlevens NM; Billaud EM; Kosterink JG; Verweij PE; Burger DM
Clin Infect Dis; 2009 May; 48(10):1441-58. PubMed ID: 19361301
[TBL] [Abstract][Full Text] [Related]
13. Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients.
Gubbins PO
Curr Opin Infect Dis; 2007 Dec; 20(6):579-86. PubMed ID: 17975407
[TBL] [Abstract][Full Text] [Related]
14. Antifungal drug resistance to azoles and polyenes.
Masiá Canuto M; Gutiérrez Rodero F
Lancet Infect Dis; 2002 Sep; 2(9):550-63. PubMed ID: 12206971
[TBL] [Abstract][Full Text] [Related]
15. A new era of antifungal therapy.
Wingard JR; Leather H
Biol Blood Marrow Transplant; 2004 Feb; 10(2):73-90. PubMed ID: 14750074
[TBL] [Abstract][Full Text] [Related]
16. SPK-843 (Aparts/Kaken).
Kasanah N; Hamann MT
Curr Opin Investig Drugs; 2005 Aug; 6(8):845-53. PubMed ID: 16121692
[TBL] [Abstract][Full Text] [Related]
17. [Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine].
Martínez-Suárez JV; Rodríguez-Tudela JL
Enferm Infecc Microbiol Clin; 1996; 14(6):384-9. PubMed ID: 8756218
[No Abstract] [Full Text] [Related]
18. Drugs in Clinical Development for Fungal Infections.
Gonzalez-Lara MF; Sifuentes-Osornio J; Ostrosky-Zeichner L
Drugs; 2017 Sep; 77(14):1505-1518. PubMed ID: 28840541
[TBL] [Abstract][Full Text] [Related]
19. Antifungal azoles: old and new.
Blyth CC
Pediatr Infect Dis J; 2011 Jun; 30(6):506-7. PubMed ID: 21587027
[No Abstract] [Full Text] [Related]
20. Antifungal drugs on the horizon.
Hay RJ
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S82-6. PubMed ID: 8077515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
